Miller Edward's Form 4 filing
Kalaris Therapeutics, Inc. (KLRS) · filed Jan 13, 2025
- Accession no.
- 0000950170-25-004834
- Filed
- Jan 13, 2025, 4:15 PM ET
- Trade date
- Jan 10, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $180. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Miller EdwardCIK 0001619252 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2025 | Common Stock | SSaleDisposed | −409 | $0.4401 | −$180 | 153,541 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.